MAPT and Alzheimer disease: Indeed, there is now substantial genetic and experimental evidence indicating that the enhanced activation of glial cells (both microglia and astrocytes) in the brain results in inflammatory consequences that are important for the progression of AD and may even help to drive AD pathology independently of Aβ deposition or tau aggregation [4].